Core Viewpoint - Harrow, Inc. is conducting its Q4 2024 earnings conference call, indicating a focus on financial performance and future outlook [1][3]. Group 1: Company Overview - Harrow, Inc. is listed on NASDAQ under the ticker HROW [1]. - The earnings conference call is scheduled for March 28, 2025, at 8:00 AM ET [1]. Group 2: Participants - The call features key company participants including Jamie Webb (Director of Communications & IR), Mark Baum (CEO), and Andrew Boll (CFO) [1]. - Various analysts from firms such as Craig Hallum, Lake Street Capital Markets, and B. Riley Securities are participating in the Q&A session [1]. Group 3: Forward-Looking Statements - The company’s remarks may include forward-looking statements, which are subject to risks and uncertainties beyond Harrow's control [3]. - Risks include the ability to commercially launch FDA-approved products and the timely approval of certain drug candidates [3].
Harrow, Inc. (HROW) Q4 2024 Earnings Conference Call